Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 On August 3, 2015

Jul 27, 2015, 13:49 ET from Array BioPharma Inc.

BOULDER, Colo., July 27, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq:   ARRY) will report financial results for the fourth quarter and full year of fiscal 2015 and hold a conference call to discuss those results on Monday, August 3, 2015.  Ron Squarer, Chief Executive Officer will lead the call.

 

Date:          

Monday, August 3, 2015

Time:          

9:00 a.m. Eastern Time

Toll-Free:     

(844) 464-3927

Toll:              

(765) 507-2598

Pass Code:    

68380312

Webcast, including Replay and Conference Call Slides:  

http://edge.media-server.com/m/p/999aon7i/lan/en 

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing. These programs include three cancer drugs, binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.

CONTACT:   

Tricia Haugeto                         


Array BioPharma Inc.


(303) 386-1193


thaugeto@arraybiopharma.com

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

 

SOURCE Array BioPharma Inc.



RELATED LINKS

http://www.arraybiopharma.com